Multidrug resistance-1 (MDR-1) in autoimmune disorders III: Increased P-glycoprotein activity inlymphocytes from immune thrombocytopenic purpura patients

By Ruiz-Soto R.   Richaud-Patin Y.   Lopez-Karpovitch X.   Llorente L.  

Experimental Hematology, Vol. 31, Iss. 6, 2003-06 ,pp. : 483-487

Elsevier

Access to resources Recommend Favorite

Vincristine resistance development in lymphoblastoid cells under conditions of selective P-glycoprotein inhibition

By Svirnovski Arcadi   Pasiukov Vadim   Grigorovich Sergei  

Hematology, Vol. 10, Iss. 4, 2005-08 ,pp. : 313-319

Maney Publishing

Access to resources Recommend Favorite

Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report

By Ding H.J.   Huang W.T.   Tsai C.S.   Chang C.S.   Kao A.  

Nuclear Medicine and Biology, Vol. 30, Iss. 5, 2003-05 ,pp. : 471-475

Elsevier

Access to resources Recommend Favorite

Significance of lung resistance-related protein in clinical outcome of acute leukemic patients with reference to p-glycoprotein

By Motoji T.   Tsuji K.   Wang Y.-H.   Motomura S.   Mizoguchi H.  

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1499-1499

Elsevier

Access to resources Recommend Favorite

Cellular and Biophysical Evidence for Interactions between Adenosine Triphosphate and P-Glycoprotein Substrates: Functional Implications for Adenosine Triphosphate/Drug Cotransport in P-Glycoprotein Overexpressing Tumor Cells and in P-Glycoprotein Low-Level Expressing Erythrocytes

By Abraham E.H.   Shrivastav B.   Salikhova A.Y.   Sterling K.M.   Johnston N.   Guidotti G.   Scala S.   Litman T.   Chan K.C.   Arceci R.J.   Steiglitz K.   Herscher L.   Okunieff P.  

Blood Cells, Molecules, and Diseases, Vol. 27, Iss. 1, 2001-01 ,pp. : 181-200

Academic Press

Access to resources Recommend Favorite